Biopharma manufacturing in UAE
Abu Dhabi ’s sovereign investment arm will establish a new unit, operated by Resilience, in the Emirates to manufacture biopharmaceutical-related products The Abu Dhabi unit will be the first “goods manufacturing practice” biopharma facility in the UAE, and the first in the region to manufacture essential life sciences products for advanced biologics, Mubadala said. We are actively investing in innovation and firmly believe that by strengthening Abu Dhabi’s national life sciences ecosystem, we are building a future focused, sustainable and knowledge based economy,” said Badr Al Olama, executive director of the UAE Investment Platform at Mubadala. “Through this agreement, Mubadala and its group companies will unlock further opportunities for growth within the life sciences ecosystem, and alongside our key partners, will play an instrumental role in establishing a state-of-the-art biopharma campus that will secure the region’s supply chain from Abu Dhabi.” We...